跳至主要内容
临床试验/NCT07512869
NCT07512869招募中不适用

Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation Study

Institute of HIV Research and Innovation Foundation, Thailand1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2025年2月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
76
试验地点
1
主要终点
Substance use-related harm assessed by self-administered questionnaire

研究概览

简要总结

This study evaluates the pre-implementation phase of a host-led harm reduction model for men who have sex with men (MSM) engaging in chemsex in Bangkok, Thailand, focusing on understanding harms, contexts, and needs to develop a tailored intervention.

详细描述

HAMMOCK is a cross-sectional mixed-methods study designed to explore chemsex practices among MSM, including both hosts and guests, as well as key stakeholders such as CSOs, hospital staff, and police.

The study aims to:

  • Explore substance-related, sexual health, mental health, and socio-legal harms
  • Understand the context and dynamics of private chemsex parties
  • Co-develop a novel host-led harm reduction model
  • Identify barriers and facilitators to implementation The study includes both quantitative (self-administered questionnaires) and qualitative (in-depth interviews) components and follows a two-phase approach: exploration and preparation phases under the EPIS framework.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • MSM aged ≥18 years
  • Able to communicate in Thai
  • Specific by group:
  • Chemsex hosts: hosted ≥2 times in past 6 months
  • Chemsex guests: attended ≥2 times in past 6 months
  • CSO / hospital / police staff: working ≥3 months in related roles
  • Provide informed consent

排除标准

  • Unable to provide informed consent (e.g., under substance influence at consent)

研究组 & 干预措施

Single Arm - Mixed-method Harm Reduction Model Development

Participants (chemsex party hosts, guests, CSO staff, hospital staff, and police officers) will participate in a mixed-method study consisting of two phases (Exploration and Preparation) to assess harms related to chemsex and to develop and refine a novel harm reduction model for private chemsex party settings.

干预措施: Self-administered questionnaire assessment (Behavioral)

Single Arm - Mixed-method Harm Reduction Model Development

Participants (chemsex party hosts, guests, CSO staff, hospital staff, and police officers) will participate in a mixed-method study consisting of two phases (Exploration and Preparation) to assess harms related to chemsex and to develop and refine a novel harm reduction model for private chemsex party settings.

干预措施: Semi-structured in-depth interviews (IDIs) (Behavioral)

Single Arm - Mixed-method Harm Reduction Model Development

Participants (chemsex party hosts, guests, CSO staff, hospital staff, and police officers) will participate in a mixed-method study consisting of two phases (Exploration and Preparation) to assess harms related to chemsex and to develop and refine a novel harm reduction model for private chemsex party settings.

干预措施: Development and refinement of harm reduction model (Behavioral)

结局指标

主要结局

Substance use-related harm assessed by self-administered questionnaire

时间窗: Baseline (during Exploration phase, prior to model development)

Substance-related harms will be assessed using a structured self-administered questionnaire. The assessment includes: * Patterns of substance use (snorting, injecting, ingesting, anal insertion) * Frequency of use * Physical harms (e.g., injection-related injuries, overdose) * Psychological harms (e.g., substance dependence) This is a descriptive assessment; no composite scale score is generated.

Sexual health risk behaviors assessed by self-administered questionnaire

时间窗: Baseline (during Exploration phase, prior to model development)

Sexual health risks will be assessed using a structured questionnaire including: * Number of sexual partners * Condom use * HIV/STI testing history * Self-reported HIV status * Pre-exposure prophylaxis (PrEP) use and adherence * Antiretroviral therapy (ART) adherence among participants living with HIV This is a descriptive assessment; no composite scale score is generated.

Depression severity assessed by Patient Health Questionnaire-9 (PHQ-9)

时间窗: Baseline (during Exploration phase, prior to model development)

Depression will be assessed using the Patient Health Questionnaire-9 (PHQ-9): * Score range: 0 to 27 * Interpretation: * 0-4: Minimal depression * 5-9: Mild * 10-14: Moderate * 15-19: Moderately severe * 20-27: Severe Higher scores indicate worse depression severity

Anxiety severity assessed by Generalized Anxiety Disorder-7 (GAD-7)

时间窗: Baseline (during Exploration phase, prior to model development)

Anxiety will be measured using the Generalized Anxiety Disorder-7 (GAD-7): * Score range: 0 to 21 * Interpretation: * 0-4: Minimal * 5-9: Mild * 10-14: Moderate * 15-21: Severe Higher scores indicate worse anxiety

次要结局

  • Perceived stigma and socio-legal harm assessed by structured questionnaire(Baseline (during Exploration phase, prior to model development))

研究者

发起方
Institute of HIV Research and Innovation Foundation, Thailand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验